LRN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Stride, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
LRN GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Stride securities between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”).
INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
INSP GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) and certain of its officers.
FLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Firefly Aerospace Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
FLY GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NYSE: FLY) and certain of its officers.
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
TLX GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ: TLX) and certain of its officers.
PRMB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Primo Brands Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
PRMB GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Primo Brands Corporation (“Primo” or “the Company”) (NYSE: PRMB; PRMW) and certain of its officers.
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
ATYR GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) and certain of its officers.
Jones Lang Stock Gains 50% in 6 Months: Will it Continue to Rise? — Positive
JLL Zacks Investment Research — November 27, 2025JLL stock rises 50% in six months, fueled by strong earnings, outsourcing demand, strategic tech investments and solid balance sheet strength.
PVH Corp. Set to Report Pre-Q3 Earnings: What's in Store for the Stock? — Negative
PVH Zacks Investment Research — November 27, 2025PVH is likely to witness Q3 earnings drop as margin pressures, China softness and tariffs weigh, despite resilient brands and a modest sales outlook.
ROSEN, A LEADING LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN — Neutral
LRN GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline.
ROSEN, A LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE — Neutral
SKYE GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.
Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
ZION GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP) resulting from allegations that Zions Bancorporation may have issued materially misleading business information to the investing public.
FLY Investor News: If You Have Suffered Losses in Firefly Aerospace Inc. (NASDAQ: FLY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
FLY GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public.
SEC investigates Jefferies over First Brands collapse, report says — Negative
JEF CNBC — November 27, 2025The newspaper, citing people with knowledge of the matter, said the regulator is looking into whether Jefferies gave investors enough information on its Point Bonita fund's exposure to the failed auto business. The inquiry into internal controls and potential conflicts within the bank is at an early stage, the report said.
Jacobs & Arcadis JV Wins New Rail Project From TMR in Australia — Positive
J Zacks Investment Research — November 27, 2025J lands a major Queensland rail upgrade, boosting its infrastructure portfolio and adding momentum to the recent stock gains.
Can Opendoor's Expanding D2C Funnel Drive a Capital-Light Strategy? — Positive
OPEN Zacks Investment Research — November 27, 2025OPEN's push to reopen and scale its D2C funnel aims to boost conversion and pave the way for a more capital-light transaction model.
JEF BREAKING NEWS: Jefferies Financial Group Inc. Faces SEC Probe Over Point Bonita Disclosures – Investors Urged to Contact BFA Law about its Investigation — Neutral
JEF Business Wire — November 27, 2025NEW YORK--(BUSINESS WIRE)---- $JEF #BFA--Jefferies Financial Group Inc. Faces SEC Probe Over Point Bonita Disclosures – Investors Urged to Contact BFA Law about its Investigation.
Trying To Give A Credit Rating For Sound Point Meridian Capital Inc — Neutral
SPMA SPMC SPME Seeking Alpha — November 27, 2025Sound Point Meridian Capital Inc is a CLO CEF fund primarily exposed to CLO equity tranches, analyzed using Moody's adapted BDC methodology. SPMC demonstrates strong asset coverage, no secured debt, and solid profitability, but its portfolio concentration in CLO equity tranches increases risk. SPMC's fixed debt appears relatively safe and close to investment grade, but the preferred shares and overall CEF CLO structure carry significant risk, which falls entirely on equity investors.
Arteris: The Hidden Gem Powering The Chiplet Revolution — Positive
AIP Seeking Alpha — November 27, 2025Arteris is well-positioned in the semiconductor industry, leveraging its FlexNoC 5 and NCore technologies to address chiplet and interconnect complexity. Arteris' strong recurring revenue growth, high gross margins, and recent positive free cash flow signal improving financial health and operational efficiency. Valuation remains attractive, with shares trading below peers and a calculated fair value of $17 per share, offering potential upside from current levels.
Exclusive: MSC, BlackRock bid for Hutchison's Barcelona terminal faces EU probe, source says — Negative
BLK Reuters — November 27, 2025BlackRock and MSC's bid for most of CK Hutchison's global port operations faces a hurdle in Europe with EU antitrust regulators set to investigate the Spanish portion of the deal, a person with direct knowledge of the matter said on Thursday.
SBUX Green Apron Gains Traction: Will Staffing Boost Traffic? — Positive
SBUX Zacks Investment Research — November 27, 2025Starbucks' Green Apron push lifts service scores and speeds, but sustained traffic gains hinge on consistent staffing as holiday demand builds.